Breaking News
0

Bond Yield Curve Inverts: 3 Defensive Stocks To Buy

By Zacks Investment ResearchStock MarketsAug 15, 2019 12:38AM ET
www.investing.com/analysis/bond-yield-curve-inverts-3-defensive-stocks-to-buy-200455574
Bond Yield Curve Inverts: 3 Defensive Stocks To Buy
By Zacks Investment Research   |  Aug 15, 2019 12:38AM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 

The U.S. bond market has indicated what some people believe to be the biggest warning of an upcoming recession. The spread between the 2-year treasury yield and the 10-year yield inverted, with the 2-year yield climbing higher than the benchmark 10-year yield for the first time since 2007.

On top of that, the U.S. 30-year bond yield fell to a record low early Wednesday, dropping down to 2.105% for the first time ever. Bond yield drops were not exclusive to the U.S., yields across Europe fell with the German 10-year bund reaching a new low of -0.65%. Strategists believe that a yield curve must stay inverted for it to truly signal a recession. Therefore, current bond yields are cause for concern only if they remain inverted. An inverted bond yield curve has been a reliable indicator of economic contractions but it does not always precede a recession.

With some bond yields at all-time lows amid broader economic uncertainty, investors have turned toward defensive stocks. Let’s take a closer look at a few stocks that can perform well during global economic uncertainty.

Procter & Gamble (NYSE:PG) is part of the consumer staples industry that is often seen as a relatively defensive move during market unpredictability. PG is a Zacks Rank #2 (Buy) right now and its shares have climbed 27.7% in 2019, with the broader soaps and cosmetics market trailing close behind, up 20%.

PG had a solid Q4 2019, beating earnings and revenue estimates by 3.77% and 1.31%, respectively. Furthermore, both revenue and earnings grew Y/Y in Q4. Zacks Consensus estimates project PG’s growth to continue in Q1 2019 with earnings projected to climb 10.71% and revenue to pop 4.82% to $17.49 billion. Furthermore, estimate revisions have ticked favorably in the right direction for PG as the chart below shows.

Kimberly-Clark (NYSE:KMB) is another consumer staples stock that has had a strong year, with KMB stock up 22%. The company operates some of the most recognizable personal care brands such as: Huggies, Pull-Ups, Kleenex, and Scott. Kimberly-Clark continued its strong 2019 with a second-quarter earnings beat that saw its EPS jump 5% to $1.67 per share.

KMB also raised its full-year earnings outlook to $6.65-$6.80, up from management’s previous estimate of $6.50-$6.70. Consensus estimates calls for KMB to sustain this bottom-line growth in Q3 with a jump of 4.68% to $1.79 on the back of 2.02% higher sales that would see it reach to $4.67 billion. Positive top and bottom-line growth is projected through 2020 and Kimberly-Clark sports a Zacks Rank #2 (Buy).

Chesapeake Utilities (NYSE:CPK) is a utility company engaged in natural gas distribution and transmission. Utilities are generally more stable stocks as the demand for electricity and gas often remains constant despite broader economic conditions. Utilities companies are also non-cyclical and don’t often move with larger market trends. CPK has a beta of 0.24 and pays out a quarterly dividend of $1.62, with a yield of 1.75% at the moment.

Chesapeake’s quarterly dividend paired with its low volatility can provide investors with a secure defensive investment. Consensus estimates also forecast CPK’s bottom-line to spike 5.88%, while sales surge 21.33% to $170.2 million in Q3. Looking ahead to the company’s full fiscal year outlook, estimates call for earnings to pop 12.39% to $3.72 and revenue to grow 6.95% to $767.37 million. Like its defensive peers, CPK is Zacks Rank #2 (Buy) at the moment.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>



Chesapeake Utilities Corporation (CPK): Free Stock Analysis Report

Kimberly-Clark Corporation (KMB): Free Stock Analysis Report

Procter & Gamble Company (The) (PG): Free Stock Analysis Report

Original post

Zacks Investment Research
Bond Yield Curve Inverts: 3 Defensive Stocks To Buy
 
Bond Yield Curve Inverts: 3 Defensive Stocks To Buy

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email